| Effect | Decrease |
| Trial Design | Cohort |
| Trial Length | 1-6 months |
| Number of Subjects | 25 |
| Sex | Both Genders |
| Age Range | 30-44, 45-64 |
| Body Types | Overweight |
300mg of Aronox (100mg thrice daily) in persons with high cholesterol was associated with a reduction in total cholesterol and improvement in lipid peroxidation of red blood cells.
